Anju Singh joined Southern Research’s Drug Discovery division in 2015. Her research interests are focused in the fields of infectious diseases and immunology. She has extensive experience working under Biosafety Level 3 (BSL3) containment conditions with virulent pathogens such as Mycobacterium tuberculosis and Francisella tularensis. Singh is particularly interested in: elucidating the mechanisms involved in host-pathogen interactions and the development of innate immunity; and discovering targets for early therapeutic intervention against various intracellular bacterial respiratory diseases.
She received her Masters of Science in biotechnology at the Indian Institute of Technology in Roorkee, and subsequently, her doctorate of philosophy at All India Institute of Medical Sciences (AIIMS) in New Delhi, India. Prior to joining Southern Research, she worked at the Trudeau Institute in Saranac Lake, New York, and at Albany Medical College in Albany, New York